Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer’s Disease: A Phase II Double-Blind Placebo-Controlled Trial
Titel:
Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer’s Disease: A Phase II Double-Blind Placebo-Controlled Trial
Auteur:
Hannestad, Jonas Duclos, Tiffanie Chao, Whitney Koborsi, Katie Klutzaritz, Vicki Beck, Brian Patel, Ashok K. Scott, James Thein, Stephen G. Cummings, Jeffrey L. Kay, Gary Braithwaite, Steven Nikolich, Karoly Albensi, Benedict